TY  - GEN

T1  - The cost-effectiveness of expanding the NHS newborn bloodspot screening programme to include homocystinuria (HCU), maple syrup urine disease (MSUD), glutaric aciduria type 1 (GA1), isovaleric acidaemia (IVA), and long-chain hydroxyl acyl-CoA dehydrogenase deficiency (LCHADD) (2014)

PY  - -0001/11/30

AU  - Bessey A

AU  - Chilcott J

AU  - Paisley S

AU  - Pandor A

ED  - 

Y2  - 2024/12/22

ER  -